// App-Quantinova.ai

TCT-41 : A Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin-Strut Sirolimus-Eluting Coronary Stent Supraflex: 2-Year Results of the TALENT Trial

Researchers

Presenter

  • Patrick Serruys

Principal Investigators

  • Robert de Winter

  • Norihiro Kogame

  • Rodrigo Modolo

  • Pim Tonino

  • Sjoerd H. Hofma

  • Pieter Smits

  • Janusz Prokopczuk

  • Raul Moreno

  • Anirban Choudhury

  • Ivo Petrov

  • Angel Cequier

  • Neville Kukreja

  • Imre Ungi

  • Antonio Serra

  • Robert Gil

  • Simon Walsh

  • Anthony Mathur

  • Bela Merkely

  • Antonio Colombo

  • Alexander Ijsselmuiden

  • Osama Soliman

  • Yoshinobu Onuma

Medical Centers

  • Imperial College, Rotterdam, the Netherlands

  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • Universisty of Szeged, Szeged, Hungary

  • PAKS Kędzierzyn- Koźle, Kędzierzyn- Koźle, Poland

  • Semmelweis University, Cardiac and Vascular Center, Budapest, Hungary

  • Catharina Hospital, Eindhoven, the Netherlands

  • Bellvitge University Hospital, Barcelona, Spain

  • Amphia Hospital, Breda, the Netherlands

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

  • Hertfordshire Cardiac Centre, Stevenage, United Kingdom

  • Acibadem City Clinic Cardiovascular Center, Sofia University, Sofia, Bulgaria

  • Academisch Medisch Centrum, Amsterdam, Netherlands

  • University Hospital La Paz, Madrid, Spain

  • Belfast Health and Social Care Trust, Belfast, United Kingdom

  • GVM Care and Research, Maria Cecilia Hospital, Cotignola, Italy

  • University Hospital of Wales, Cardiff, United Kingdom

  • Barts Heart Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom

  • Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland

  • Freeman Hospital and Newcastle University, Newcastle upon Tyne, United Kingdom

  • Department of Cardiology, Medisch Centrum Leeuwarden, Leeuwarden, Netherlands

  • Thoraxcenter Erasmus Medical Center, Rotterdam, the Netherlands

  • Erasmus MC- Cardialysis, Rotterdam, the Netherlands

Locations

  • Netherlands

  • United Kingdom

  • Poland

  • Spain

  • Italy

  • Hungary

  • Bulgaria

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • Excel II

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Non Inferiority

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved